AIDX
20/20 Biolabs, Inc.
Company overview
- Market capitalization
- $5.22M
- Employees
- 4
- Latest publication
- 2026-09-29
About 20/20 Biolabs, Inc.
20/20 Biolabs, Inc. develops and commercializes AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. It provides OneTest for Cancer, a multi-cancer early detection, or MCED and OneTest for Longevity, which measures inflammatory biomarkers. It also operates the Clinical Lab Innovation Axcelerator (CLIAx), a CLIA laboratory for overseas diagnostics start-ups. The company was formerly known as 20/20 GeneSystems, Inc. and changed its name to 20/20 Biolabs, Inc. in March 2025. The company was incorporated in 2000 and is based in Gaithersburg, Maryland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20232023-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 730,571USD | 353,375USD | 538,274USD | 417,979USD | 553,820USD | 536,084USD | 361,009USD | 335,936USD |
| Cost Of Revenue | 425,844USD | 290,491USD | 407,857USD | 272,913USD | 388,025USD | 373,054USD | 336,869USD | 296,817USD |
| Gross Profit | 304,727USD | 62,884USD | 130,417USD | 145,066USD | 165,795USD | 163,030USD | 24,140USD | 39,119USD |
| Research Development | 257,632USD | 153,482USD | 130,554USD | 131,060USD | 136,831USD | 446,056USD | 297,099USD | 513,722USD |
| Selling General Administrative | 1,291,318USD | 1,352,758USD | 912,709USD | — | 801,144USD | 960,972USD | — | — |
| Total Operating Expenses | 1,548,950USD | 1,506,240USD | 1,451,120USD | 945,239USD | 1,326,000USD | 1,407,028USD | 1,914,590USD | 1,806,286USD |
| Operating Income | -1,244,223USD | -1,443,356USD | -912,846USD | -800,173USD | -772,180USD | -1,243,998USD | -1,890,450USD | -1,767,167USD |
| Total Other Income Expense Net | -262,120USD | -677,288USD | -273,027USD | -25,366USD | -115USD | -5,050USD | 16,926USD | 50,438USD |
| Interest Income | 14,476USD | 6,653USD | 3,087USD | — | 8,458USD | 11,270USD | — | — |
| Interest Expense | 272,245USD | 267,008USD | 124,985USD | 29,547USD | 740USD | 0USD | — | 7,096USD |
| Net Income | -1,506,343USD | -2,120,644USD | -1,307,771USD | -825,539USD | -764,577USD | -1,249,048USD | -1,873,524USD | -1,716,729USD |
| Net Income Applicable To Common Shares | -2,752,681USD | — | — | — | — | — | — | — |
| Net Interest Income | — | -260,355USD | -121,898USD | — | 7,718USD | 11,270USD | — | — |
| Income Before Tax | — | -2,120,644USD | -1,307,771USD | -825,539USD | -764,577USD | -1,249,048USD | -1,873,524USD | -1,716,729USD |
| Tax Provision | — | 0USD | 0USD | — | 0USD | 0USD | — | — |
| Net Income From Continuing Ops | — | -2,174,836USD | -1,307,771USD | — | -764,577USD | -1,249,048USD | — | — |
| Ebitda | — | -1,443,356USD | — | -780,949USD | — | -1,217,473USD | -1,856,302USD | -1,727,172USD |
| Reconciled Depreciation | — | 14,811USD | 17,874USD | — | 21,612USD | 31,575USD | — | — |
| Ebit | — | — | — | -800,173USD | — | -1,249,048USD | -1,890,450USD | -1,767,167USD |
| Depreciation And Amortization | — | — | — | 19,224USD | — | 31,575USD | 34,148USD | 39,995USD |
| Unclassified Operating Expenses | — | — | — | — | — | — | 1,617,491USD | 1,292,564USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,045,133USD | 1,752,343USD | 1,424,304USD | 11,059,145USD | 9,622,332USD | 2,330,528USD | 288,300USD | 277,047USD |
| Cost Of Revenue | 1,440,592USD | 1,392,032USD | 1,315,166USD | 5,937,398USD | 4,927,374USD | 1,453,354USD | 263,917USD | 217,595USD |
| Gross Profit | 604,541USD | 360,311USD | 109,138USD | 5,121,747USD | 4,694,958USD | 877,174USD | 24,383USD | 59,452USD |
| Research Development | 592,569USD | 1,261,781USD | 1,409,150USD | 120,043USD | 193,368USD | 338,874USD | 195,041USD | 234,492USD |
| Selling General Administrative | 3,342,843USD | 4,759,587USD | 5,061,450USD | — | — | — | — | — |
| Total Operating Expenses | 3,935,412USD | 6,021,368USD | 6,470,600USD | 3,442,878USD | 2,752,861USD | 2,907,648USD | 2,491,673USD | 1,533,666USD |
| Operating Income | -3,330,871USD | -5,661,057USD | -6,361,462USD | 1,678,869USD | 1,942,097USD | -2,030,474USD | -2,467,290USD | -1,474,214USD |
| Interest Income | 21,399USD | 79,467USD | 209,150USD | — | — | — | — | — |
| Interest Expense | 156,207,000USD | 12,646USD | 27,915USD | 15,685USD | 12,930USD | — | — | — |
| Net Interest Income | -134,808USD | 66,821USD | 181,235USD | — | — | — | — | — |
| Income Before Tax | -3,738,821USD | -5,551,667USD | -6,391,309USD | 2,186,875USD | 2,071,777USD | -2,021,826USD | -2,425,338USD | -1,463,105USD |
| Tax Provision | 0USD | 0USD | 0USD | — | — | — | — | — |
| Net Income | -3,738,821USD | -5,551,667USD | -6,391,309USD | 2,186,875USD | 2,071,777USD | -2,021,826USD | -2,425,338USD | -1,463,105USD |
| Net Income From Continuing Ops | -3,738,821USD | -5,551,667USD | -6,391,309USD | — | — | — | — | — |
| Ebitda | -3,330,871USD | -5,525,300USD | -6,194,169USD | 1,967,558USD | 2,065,758USD | -1,965,345USD | -2,423,382USD | -1,443,454USD |
| Reconciled Depreciation | 77,976USD | 135,757USD | 167,293USD | — | — | — | — | — |
| Total Other Income Expense Net | -407,950USD | 109,390USD | -29,847USD | 508,006USD | 129,680USD | 8,648USD | 41,952USD | 11,109USD |
| Ebit | — | -5,661,057USD | -6,361,462USD | 1,678,869USD | 1,942,097USD | -2,030,474USD | -2,467,290USD | -1,474,214USD |
| Depreciation And Amortization | — | 135,757USD | 167,293USD | 288,689USD | 123,661USD | 65,129USD | 43,908USD | 30,760USD |
| Unclassified Operating Expenses | — | — | — | 3,322,835USD | 2,559,493USD | 2,568,774USD | 2,296,632USD | 1,299,174USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q3 20252025-09-30 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20232023-06-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|---|
| Total Assets | 6,123,185USD | 5,803,347USD | 3,239,449USD | 3,613,142USD | — | 8,831,259USD | 10,746,180USD |
| Cash And Equivalents | 4,546,140USD | — | — | — | — | — | — |
| Total Current Assets | 5,075,623USD | 4,700,277USD | 1,565,774USD | 2,034,225USD | — | 6,672,541USD | 8,502,838USD |
| Other Current Assets | 126,961USD | 175,174USD | 229,284USD | 67,780USD | — | 162,134USD | 228,602USD |
| Other Non Current Assets | 23,057USD | — | — | — | — | — | — |
| Total Liabilities | 2,963,877USD | — | — | — | — | — | — |
| Total Current Liabilities | 2,551,236USD | 2,580,045USD | 1,992,152USD | 1,355,078USD | — | 1,112,496USD | 1,442,922USD |
| Other Current Liabilities | 743,001USD | — | — | — | — | — | — |
| Total Stockholder Equity | 1,620,700USD | 2,552,886USD | 108,456USD | 1,534,216USD | — | 6,578,320USD | 8,127,666USD |
| Total Equity Including Noncontrolling Interest | 3,159,308USD | — | — | — | — | — | — |
| Deferred Revenue | 467,033USD | — | — | — | — | — | — |
| Deferred Revenue Non Current | 32,924USD | — | — | — | — | — | — |
| Net Receivables | 291,486USD | 201,481USD | 136,873USD | 135,272USD | — | 223,951USD | 618,721USD |
| Inventory | 111,036USD | 104,523USD | 54,762USD | 47,164USD | — | 73,700USD | 101,175USD |
| Property Plant Equipment Net | 553,002USD | 607,694USD | 718,034USD | 889,054USD | — | 1,308,279USD | 1,375,192USD |
| Intangible Assets | 205,985USD | 206,801USD | 479,848USD | 499,172USD | — | 525,307USD | 799,274USD |
| Accounts Payable | 1,026,809USD | 980,486USD | 628,384USD | 372,303USD | — | 419,014USD | 372,754USD |
| Short Term Debt | 192,731USD | 189,649USD | 173,349USD | 165,702USD | — | 174,186USD | 187,141USD |
| Common Stock | 122,512USD | 104,430USD | 49,172USD | 48,231USD | — | 47,653USD | 47,653USD |
| Retained Earnings | -36,928,398USD | -35,422,055USD | -31,939,448USD | -29,508,398USD | — | -21,276,963USD | -19,560,234USD |
| Total Liab | — | 466,177USD | 3,130,993USD | 2,078,926USD | — | 2,252,939USD | 2,618,514USD |
| Other Current Liab | — | 959,243USD | 681,631USD | 346,622USD | — | 165,507USD | 508,255USD |
| Capital Stock | — | 308,669USD | 96,346USD | 95,013USD | — | — | — |
| Cash | — | 4,219,099USD | 1,144,855USD | 1,784,009USD | — | 6,212,756USD | 7,554,340USD |
| Cash And Short Term Investments | — | 4,219,099USD | 1,144,855USD | 1,784,009USD | — | 6,212,756USD | 7,554,340USD |
| Current Deferred Revenue | — | 450,667USD | 508,788USD | 470,451USD | — | 353,789USD | 374,772USD |
| Net Debt | — | -3,600,328USD | 550,910USD | -270,611USD | — | -3,975,745USD | -5,228,571USD |
| Short Long Term Debt | — | 306,716USD | — | — | — | — | — |
| Short Long Term Debt Total | — | 618,771USD | 1,695,765USD | 1,513,398USD | — | 2,237,011USD | 2,325,769USD |
| Property Plant Equipment Gross | — | 1,783,388USD | 1,228,909USD | 1,353,635USD | — | — | — |
| Common Stock Shares Outstanding | — | 7,657,229shares | 4,856,000shares | 4,804,000shares | 4,804,000shares | 4,769,000shares | 4,765,167shares |
| Non Current Assets Total | — | 1,103,070USD | 1,673,675USD | 1,578,916USD | — | 2,158,717USD | 2,243,342USD |
| Non Current Liabilities Total | — | 429,122USD | 1,138,841USD | 723,848USD | — | 1,140,443USD | 1,175,591USD |
| Non Currrent Assets Other | — | 288,575USD | 475,793USD | 161,956USD | — | 322,432USD | 66,177USD |
| Net Working Capital | — | 2,120,232USD | -426,378USD | 679,147USD | — | — | — |
| Unclassified Equity | — | 37,561,842USD | 31,902,386USD | 30,899,370USD | — | 27,807,630USD | 27,640,247USD |
| Long Term Debt | — | — | 450,498USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | — | — | — | 1,140,443USD | 1,175,591USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,613,142USD | 6,367,828USD | 12,215,021USD | 10,272,281USD | 4,677,374USD | 3,125,886USD | 4,105,209USD | 1,422,121USD |
| Intangible Assets | 499,172USD | 526,529USD | 726,841USD | 581,598USD | 620,882USD | 658,024USD | 641,995USD | 200,559USD |
| Other Current Assets | 67,780USD | 81,469USD | 72,270USD | 125,664USD | 50,165USD | 51,567USD | 16,478USD | 11,020USD |
| Total Liab | 2,078,926USD | 2,080,336USD | 2,840,755USD | 3,382,484USD | 1,288,155USD | 976,560USD | 820,542USD | 965,937USD |
| Total Stockholder Equity | 1,534,216USD | 4,287,492USD | 9,374,266USD | 6,889,797USD | 3,389,219USD | 2,149,326USD | 3,284,667USD | 456,184USD |
| Other Current Liab | 346,622USD | 232,684USD | 649,795USD | 1,121,607USD | 602,536USD | 516,063USD | 492,874USD | 499,997USD |
| Common Stock | 48,231USD | 47,731USD | 47,648USD | 47,626USD | 47,288USD | 47,256USD | 47,256USD | 46,326USD |
| Capital Stock | 95,013USD | 93,889USD | — | — | — | — | — | — |
| Retained Earnings | -29,508,398USD | -23,956,731USD | -17,565,422USD | -19,752,297USD | -21,824,074USD | -19,802,248USD | -17,376,910USD | -15,913,805USD |
| Cash | 1,784,009USD | 4,089,461USD | 8,807,575USD | 3,354,469USD | 3,468,192USD | 636,018USD | 3,273,494USD | 1,040,083USD |
| Cash And Short Term Investments | 1,784,009USD | 4,089,461USD | 8,807,575USD | 3,354,469USD | 3,468,192USD | 2,283,824USD | 3,273,494USD | 1,040,083USD |
| Total Current Assets | 2,034,225USD | 4,300,432USD | 9,731,843USD | 7,942,256USD | 3,826,869USD | 2,403,366USD | 3,331,758USD | 1,142,000USD |
| Total Current Liabilities | 1,355,078USD | 1,011,622USD | 1,630,171USD | 2,253,602USD | 1,247,908USD | 976,560USD | 820,542USD | 964,437USD |
| Current Deferred Revenue | 470,451USD | 254,871USD | 316,222USD | 152,698USD | 70,456USD | 77,775USD | — | 210,000USD |
| Net Debt | -270,611USD | -2,017,411USD | -6,393,781USD | -1,000,402USD | -3,324,085USD | -636,018USD | -3,273,494USD | -1,040,083USD |
| Short Term Debt | 165,702USD | 163,788USD | 199,872USD | 145,028USD | 103,860USD | — | — | — |
| Short Long Term Debt Total | 1,513,398USD | 2,072,050USD | 2,413,794USD | 2,354,067USD | 144,107USD | — | — | — |
| Net Receivables | 135,272USD | 68,834USD | 764,924USD | 4,215,465USD | 205,071USD | 32,498USD | 15,488USD | 53,106USD |
| Inventory | 47,164USD | 60,668USD | 87,074USD | 246,658USD | 103,441USD | 35,477USD | 26,298USD | 37,792USD |
| Accounts Payable | 372,303USD | 360,279USD | 464,282USD | 834,269USD | 471,056USD | 382,722USD | 327,668USD | 254,440USD |
| Property Plant Equipment Net | 889,054USD | 1,177,597USD | 1,669,694USD | 1,680,381USD | 205,006USD | 48,924USD | 60,994USD | 7,017USD |
| Property Plant Equipment Gross | 1,353,635USD | 1,654,839USD | — | — | — | — | — | — |
| Common Stock Shares Outstanding | 4,800,524shares | 4,768,799shares | 9,487,385shares | 9,463,282shares | 4,727,495shares | 4,725,633shares | 4,713,339shares | 4,632,608shares |
| Non Current Assets Total | 1,578,916USD | 2,067,396USD | 2,483,178USD | 2,330,024USD | 850,505USD | 722,519USD | 773,451USD | 280,119USD |
| Non Current Liabilities Total | 723,848USD | 1,068,713USD | 1,210,584USD | 1,128,882USD | 40,246USD | — | — | 1,500USD |
| Non Currrent Assets Other | 161,956USD | 363,270USD | 83,944USD | 65,346USD | 21,918USD | 12,872USD | 12,795USD | 15,389USD |
| Net Working Capital | 679,147USD | 3,288,809USD | — | — | — | — | — | — |
| Unclassified Equity | 30,899,370USD | 28,102,603USD | 26,892,040USD | 26,594,468USD | 25,166,005USD | 21,904,318USD | 20,614,321USD | 16,323,663USD |
| Long Term Debt | — | 229,164USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | — | 1,210,584USD | 1,128,882USD | — | — | — | — |
| Short Term Investments | — | — | — | — | — | 1,647,806USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 24,610USD |
| Stock Based Compensation | 499,740USD |
| Other Non Cash Items | -326,595USD |
| Change To Account Receivables | -91,532USD |
| Change To Inventory | 5,181USD |
| Change To Liabilities | 128,382USD |
| Change In Working Capital | 73,928USD |
| Operating Cash Flow | -1,894,420USD |
| Investing Cash Flow | -12,854USD |
| Financing Cash Flow | 5,427,427USD |
| Change In Cash | 3,520,153USD |
| End Cash Flow | 4,546,140USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q2 20232023-06-30 · USD | Q1 20232023-03-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -2,120,644USD | -1,307,771USD | -764,577USD | -1,249,048USD | -1,716,729USD | -1,994,812USD |
| Depreciation | 9,186USD | 17,874USD | 21,612USD | 31,575USD | 39,995USD | 53,864USD |
| Stock Based Compensation | 128,440USD | 127,230USD | 129,650USD | 652,980USD | — | — |
| Other Non Cash Items | 694,058USD | — | — | 669,336USD | 62,428USD | 958,583USD |
| Change To Account Receivables | -1,527USD | -63,081USD | 5,610USD | -28,084USD | 394,770USD | 146,203USD |
| Change To Inventory | 11,694USD | -61,454USD | -20,866USD | 4,529USD | 3,148USD | 10,226USD |
| Change In Working Capital | -68,870USD | 280,027USD | 125,022USD | 11,686USD | 207,628USD | -152,647USD |
| Total Cash From Operating Activities | -1,288,960USD | -511,667USD | -488,293USD | -536,451USD | -1,406,678USD | -1,135,012USD |
| Capital Expenditures | -5,354USD | 0USD | 0USD | 0USD | -4,682USD | 0USD |
| Free Cash Flow | -1,288,960USD | -511,667USD | -488,293USD | -536,450USD | -1,411,360USD | -1,135,010USD |
| Total Cashflows From Investing Activities | -5,354USD | — | — | — | 80,652USD | -102,916USD |
| Net Borrowings | 250,000USD | 411,911USD | 70,000USD | 0USD | — | — |
| Total Cash From Financing Activities | 4,487,426USD | 392,799USD | 262,338USD | 110,026USD | -15,558USD | -15,307USD |
| Dividends Paid | -54,192USD | — | — | — | — | — |
| Issuance Of Capital Stock | 5,000,000USD | 4,750USD | 192,338USD | 110,026USD | — | — |
| Change In Cash | 3,193,112USD | -118,868USD | -225,955USD | 1,784,009USD | -1,341,584USD | 7,554,340USD |
| Begin Period Cash Flow | 1,025,987USD | 1,144,855USD | 1,784,009USD | 2,210,434USD | 7,554,340USD | — |
| End Period Cash Flow | 4,219,099USD | 1,025,987USD | 1,558,054USD | 1,784,009USD | 6,212,756USD | 7,554,340USD |
| Other Cashflows From Investing Activities | -5,354USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | 4,541,618USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | -5,250,000USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3,738,821,000USD | -5,551,667USD | -6,391,309USD | 2,186,875USD | 2,071,777USD | -2,021,826USD | -2,425,338USD | -1,463,105USD |
| Depreciation | 77,976USD | 135,757USD | 167,293USD | 288,689USD | 123,661USD | 65,129USD | 43,908USD | 30,760USD |
| Stock Based Compensation | 516,180USD | 2,176,098USD | 1,303,952USD | — | — | — | — | — |
| Other Non Cash Items | 1,819,101,000USD | 2,197,433USD | 1,369,846USD | 205,081USD | 38,573USD | — | 140,514USD | 7,500USD |
| Change To Account Receivables | -64,682USD | -66,438USD | 696,090USD | 3,484,807USD | -4,010,394USD | -172,573USD | -17,010USD | 37,618USD |
| Change To Inventory | -69,052USD | 13,504USD | 26,406USD | 159,584USD | -143,217USD | -67,964USD | -9,179USD | 11,494USD |
| Change In Working Capital | 836,734USD | 619,692USD | 225,812USD | 3,122,414USD | -3,308,014USD | -80,692USD | 118,108USD | 110,341USD |
| Total Cash From Operating Activities | -1,919,720,000USD | -2,598,785USD | -4,628,358USD | 5,803,059USD | -1,074,003USD | -2,037,388USD | -2,122,808USD | -1,314,504USD |
| Capital Expenditures | 0USD | -5USD | -9,382USD | -261,789USD | -228,147USD | -184,072USD | -2,292USD | -64,076USD |
| Free Cash Flow | -1,919,720,000USD | -2,598,780USD | -4,637,740USD | 5,541,270USD | -1,302,150USD | -2,221,460USD | -2,125,100USD | -1,378,580USD |
| Net Borrowings | 988,472USD | 0USD | -46,575USD | — | — | — | — | — |
| Total Cash From Financing Activities | 1,161,698,000USD | 293,333USD | -45,992USD | 112,599USD | 1,188,430USD | 3,405,826USD | 1,149,484USD | 3,984,088USD |
| Issuance Of Capital Stock | 197,088USD | 293,333USD | 0USD | — | — | — | — | — |
| Change In Cash | -758,022,000USD | -2,305,452USD | -4,718,114USD | 5,453,106USD | -113,723USD | 2,832,174USD | -2,637,476USD | 2,233,411USD |
| Begin Period Cash Flow | 1,784,009,000USD | 4,089,461USD | 8,807,575USD | 3,354,469USD | 3,468,192USD | 636,018USD | 3,273,494USD | 1,040,083USD |
| End Period Cash Flow | 1,025,987,000USD | 1,784,009USD | 4,089,461USD | 8,807,575USD | 3,354,469USD | 3,468,192USD | 636,018USD | 3,273,494USD |
| Other Cashflows From Financing Activities | 1,161,698,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Cash Flow | — | -2,176,098USD | -1,303,952USD | — | — | — | — | — |
| Total Cashflows From Investing Activities | — | — | -43,764USD | -462,552USD | -228,150USD | 1,463,736USD | -1,664,152USD | -436,173USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | 1,647,806USD | -1,616,284USD | -210,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Bio Check | 21,547 | USD | 0001213900-26-059542 |
| Q1 2026Quarterly · 2026-03-31 | Product | CLIAx | 21,725 | USD | 0001213900-26-059542 |
| Q1 2026Quarterly · 2026-03-31 | Product | One Test | 310,103 | USD | 0001213900-26-059542 |
| FY 2025Yearly · 2025-12-31 | Product | Bio Check | 152,047 | USD | 0001213900-26-037667 |
| FY 2025Yearly · 2025-12-31 | Product | CLIAx | 89,379 | USD | 0001213900-26-037667 |
| FY 2025Yearly · 2025-12-31 | Product | One Test | 1,803,707 | USD | 0001213900-26-037667 |
| Q1 2025Quarterly · 2025-03-31 | Product | Bio Check | 56,967 | USD | 0001213900-26-059542 |
| Q1 2025Quarterly · 2025-03-31 | Product | CLIAx | 25,474 | USD | 0001213900-26-059542 |
| Q1 2025Quarterly · 2025-03-31 | Product | One Test | 471,379 | USD | 0001213900-26-059542 |
| FY 2024Yearly · 2024-12-31 | Product | Bio Check | 177,283 | USD | 0001213900-26-037667 |
| FY 2024Yearly · 2024-12-31 | Product | CLIAx | 84,179 | USD | 0001213900-26-037667 |
| FY 2024Yearly · 2024-12-31 | Product | One Test | 1,490,881 | USD | 0001213900-26-037667 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.